Source: International Congress 2019 – Tuberculosis: treatment and management
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Khiteva (Moscow, Russian Federation), L. Panova (Moscow, Russian Federation), E. Ovsyankina (Moscow, Russian Federation), E. Krushinskaya (Moscow, Russian Federation). New approaches to MDR/XDR TB chemotherapy in children and adolescents. 5283

Member's Comments

No comment yet.

Related content which might interest you: New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Effectiveness of treatment for MDR TB in children and adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006 Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 TB-incidence and role of preventive chemotherapy in children and adolescents from bacillary DR TB-pestholes Source: Eur Respir J 2007; 30: Suppl. 51, 413s Year: 2007 Use of shortened chemotherapy regimens in treatment of adolescents with MDR/XDR TB Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Challenges in TB treatment in adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Tolerance to chemotherapy regimens with bedaquiline in adolescents with MDR/XDR pulmonary TB Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges Source: Eur Respir J 2016; 48: 938-943 Year: 2016 Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update Source: Eur Respir J, 57 (5) 2002483; 10.1183/13993003.02483-2020 Year: 2021 The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 New and repurposed drugs for MDR-TB patients Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence  Year: 2017 New perspectives in MDR-TB management Source: International Congress 2016 – China Session II Year: 2016 Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Prioritising children and adolescents in the tuberculosis response of the WHO European Region Source: Eur Respir Rev, 28 (151) 180106; 10.1183/16000617.0106-2018 Year: 2019 Managing adult and children XDR-TB cases with limited clinical options Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Identification and clinical management of LTBI in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014